Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
Takigawa, N.; Ochi, N.; Nakagawa, N.; Nagasaki, Y.; Taoka, M.; Ichiyama, N.; Mimura, A.; Nakanishi, H.; Kohara, H.; Yamane, H. Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? Cancers 2020, 12, 1995. https://doi.org/10.3390/cancers12071995
Takigawa N, Ochi N, Nakagawa N, Nagasaki Y, Taoka M, Ichiyama N, Mimura A, Nakanishi H, Kohara H, Yamane H. Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? Cancers. 2020; 12(7):1995. https://doi.org/10.3390/cancers12071995
Chicago/Turabian StyleTakigawa, Nagio; Ochi, Nobuaki; Nakagawa, Nozomu; Nagasaki, Yasunari; Taoka, Masataka; Ichiyama, Naruhiko; Mimura, Ayaka; Nakanishi, Hidekazu; Kohara, Hiroyuki; Yamane, Hiromichi. 2020. "Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?" Cancers 12, no. 7: 1995. https://doi.org/10.3390/cancers12071995